Who are the top shareholders of the Godavari Bioref.?

The top shareholders of Godavari Bioref. include Somaiya Agencies Private Limited with 17.3%, mutual funds holding 10.95% (led by HDFC Mutual Fund at 4.1%), and individual investors at 17.64%. There are also eight foreign institutional investors with a combined 0.97%, and no pledged promoter holdings are reported.

The top shareholders of Godavari Bioref. include a mix of promoters, mutual funds, and individual investors. The majority shareholder is Somaiya Agencies Private Limited, which holds 17.3% of the company. Additionally, mutual funds collectively hold 10.95% across six schemes, with HDFC Mutual Fund - HDFC Manufacturing Fund being the highest public shareholder at 4.1%. Individual investors account for 17.64% of the holdings. There are also eight foreign institutional investors (FIIs) holding a small portion of 0.97%. Notably, there are no pledged promoter holdings reported.

Has Godavari Bioref. declared dividend?

No Dividend History Available

Who are the peers of the Godavari Bioref.?

Godavari Bioref.'s peers include Hind. Unilever, ITC, Nestle India, and others, with varying management and growth ratings. It has an average management risk and below-average capital structure, with its 1-year return not applicable.

Peers: The peers of Godavari Bioref. are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Lotus Chocolate, Vadilal Enterp., Mukka Proteins, Jindal Photo, and KSE.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Average management risk is present at Godavari Bioref., Lotus Chocolate, Vadilal Enterp., Mukka Proteins, Jindal Photo, and KSE. Growth ratings show Excellent growth at Lotus Chocolate, Good growth at Vadilal Enterp. and Mukka Proteins, while Below Average growth is noted at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, and Godavari Bioref. Capital Structure is rated Excellent for Hind. Unilever, ITC, Nestle India, Britannia Inds., and Godrej Consumer, while Below Average is noted for Godavari Bioref., Lotus Chocolate, Mukka Proteins, Jindal Photo, and KSE.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vadilal Enterp. at 215.15%, while the lowest is Godavari Bioref. with an N/A return. Godavari Bioref.'s 1-year return is not applicable, indicating it has not been reported. Additionally, peers with negative six-month returns include Lotus Chocolate, Mukka Proteins, and Godavari Bioref.

Is Godavari Bioref. overvalued or undervalued?

As of May 26, 2025, Godavari Bioref. is considered overvalued with a valuation grade of "attractive," reflected in its negative PE ratio of -53.80, high EV to EBITDA of 20.92, and low ROCE of 4.46%, especially when compared to peers like E.I.D.-Parry and Balrampur Chini Mills.

As of 26 May 2025, the valuation grade for Godavari Bioref. has moved from very attractive to attractive. The company appears to be overvalued based on its current financial metrics. Key ratios include a PE ratio of -53.80, an EV to EBITDA of 20.92, and a ROCE of 4.46%. In comparison, E.I.D.-Parry (India) Ltd. has a PE ratio of 27.55 and an EV to EBITDA of 5.63, while Balrampur Chini Mills Ltd. shows a PE of 28.14 and an EV to EBITDA of 21.19, indicating that Godavari Bioref. is trading at a significant premium relative to its peers.<BR><BR>The company's financials reflect challenges, particularly with a negative ROE of -5.49% and a PEG ratio of 0.00, suggesting limited growth prospects. While the stock has performed well recently, with a 1-month return of 74.99% compared to the Sensex's 3.80%, this may not be sustainable given the underlying valuation metrics. Overall, the analysis indicates that Godavari Bioref. is overvalued in the current market context.

What does Godavari Bioref. do?

Godavari Biorefineries Ltd is a small-cap FMCG company that specializes in biorefinery operations. As of March 2025, it reported net sales of ₹5,795 Cr and a net profit of ₹719 Cr.

Overview:<BR>Godavari Biorefineries Ltd operates in the FMCG industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Godavari Investment and Finance Corporation Limited' in 1956. It changed its name to 'Godavari Biorefineries Limited' in 2006. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 5,795 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 719 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,543 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 25 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.28 <BR>Return on Equity: -5.49% <BR>Price to Book: 3.00<BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

How big is Godavari Bioref.?

As of 24th July, Godavari Biorefineries Ltd has a market capitalization of 1,801.00 Cr, with recent net sales of 1,870.25 Cr and a net loss of 23.42 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Godavari Biorefineries Ltd has a market capitalization of 1,801.00 Cr and is classified as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest four quarters is 1,870.25 Cr, while the sum of Net Profit for the same period shows a loss of 23.42 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 500.68 Cr, and Total Assets amount to 1,991.66 Cr.

When is the next results date for Godavari Bioref.?

Godavari Bioref. will announce its results on 07 August 2025.

Godavari Bioref. will declare its results on 07 August 2025.

Are Godavari Bioref. latest results good or bad?

Godavari Biorefineries' latest results are unfavorable, with a significant decline in Profit Before Tax (PBT) to Rs -23.04 crore and Profit After Tax (PAT) to Rs -16.02 crore, alongside a 9.13% drop in net sales compared to the previous quarter. Overall, the company is facing considerable financial challenges.

The latest results for Godavari Biorefineries indicate a challenging financial situation. For the quarter ending June 2025, the company's Profit Before Tax (PBT) has significantly declined to Rs -23.04 crore, which is a drastic drop of 406.4% compared to the average PBT of Rs -4.55 crore over the previous four quarters. Similarly, the Profit After Tax (PAT) also fell sharply to Rs -16.02 crore, down 173.6% from an average of Rs -5.86 crore in the prior quarters.<BR><BR>Additionally, the company's net sales experienced a decrease of 9.13% compared to the previous quarter, which contrasts sharply with the impressive growth of 29.26% seen in March 2025. The standalone net profit showed a staggering decline of 123.74%, further highlighting the difficulties the company is facing.<BR><BR>Overall, these results suggest that Godavari Biorefineries is currently experiencing significant financial challenges, making the latest performance appear unfavorable.

How has been the historical performance of Godavari Bioref.?

Godavari Bioref. has faced significant fluctuations in financial performance, with net sales decreasing from 2,014.69 crore in March 2023 to 1,870.25 crore in March 2025, and profitability declining sharply, resulting in a profit after tax of -23.41 crore in March 2025. The company has struggled with rising expenditures and a notable drop in cash flow from operations.

Answer:<BR>The historical performance of Godavari Bioref. has shown significant fluctuations over the years, particularly in its net sales and profitability.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Godavari Bioref. reported net sales of 1,870.25 crore, an increase from 1,686.67 crore in March 2024 but a decrease from 2,014.69 crore in March 2023. The total operating income mirrored this trend, reaching 1,870.25 crore in March 2025. The company's total expenditure, excluding depreciation, rose to 1,766.60 crore in March 2025 from 1,553.13 crore in March 2024, leading to an operating profit (PBDIT) of 120.31 crore, down from 147.94 crore the previous year. This decline in profitability is reflected in the profit before tax, which fell to -1.54 crore in March 2025 from 12.45 crore in March 2024, resulting in a profit after tax of -23.41 crore compared to 12.30 crore in the prior year. The company's total assets decreased slightly to 1,955.09 crore in March 2025 from 1,991.50 crore in March 2024, while total liabilities also saw a decline to 1,955.09 crore from 1,991.50 crore. Cash flow from operating activities dropped significantly to 6.00 crore in March 2025 from 185.00 crore in March 2024, indicating challenges in generating cash from core operations. Overall, Godavari Bioref. has experienced a challenging financial environment, marked by declining profits and fluctuating sales.

Is Godavari Bioref. technically bullish or bearish?

As of December 1, 2025, the market trend has shifted to sideways with neutral indicators, as the weekly MACD and Bollinger Bands are bearish, while daily moving averages are mildly bullish but lack strong momentum.

As of 1 December 2025, the technical trend has changed from mildly bullish to sideways. The current stance is neutral, with weak indicators supporting this position. The weekly MACD is bearish, and Bollinger Bands also indicate a bearish trend. The daily moving averages are mildly bullish, but this is offset by the lack of signals from the RSI and the KST being mildly bearish. Additionally, Dow Theory shows no trend in both weekly and monthly time frames. Overall, the indicators suggest a lack of strong momentum in either direction.

Should I buy, sell or hold Godavari Bioref.?

Why is Godavari Bioref. falling/rising?

As of 02-Dec, Godavari Biorefineries Ltd's stock price is at 245.05, with a year-to-date decline of 21.98% and a one-year drop of 29.03%. Despite a slight increase today, the company's financial challenges and reduced institutional confidence indicate a continued downward trend.

As of 02-Dec, Godavari Biorefineries Ltd's stock price is currently at 245.05, reflecting a slight increase of 0.05 (0.02%). However, the stock has shown a significant decline over various periods, with a year-to-date drop of 21.98% and a one-year decrease of 29.03%. This underperformance is starkly contrasted with the Sensex, which has gained 8.96% over the same year.<BR><BR>The stock's recent performance indicates it has outperformed its sector by 0.71% today, but this is overshadowed by a broader trend of falling investor participation, as evidenced by a 41.18% decrease in delivery volume compared to the five-day average. Additionally, the stock is trading above its 200-day moving average but below its shorter-term moving averages, suggesting mixed signals regarding its price momentum.<BR><BR>Financially, the company is facing significant challenges, including operating losses and a high debt-to-EBITDA ratio of 3.11 times, which indicates a low ability to service its debt. The return on equity is also low at 6.45%, reflecting poor profitability. Furthermore, the company's profits have plummeted by 357% over the past year, contributing to the negative sentiment surrounding the stock.<BR><BR>Institutional investors have reduced their stakes by 2.04% in the last quarter, indicating a lack of confidence from those with greater analytical resources. Overall, while there may be a slight uptick in the stock price today, the underlying fundamentals and long-term performance suggest a continued downward trend for Godavari Biorefineries Ltd.

Which are the latest news on Godavari Bioref.?